HDA Honors Elsevier’s Kay Morgan with 2017 Distribution Management Award for Industry Leadership
March 7, 2017
ARLINGTON, Va. — Kay Morgan of Elsevier Clinical Solutions is the 2017 recipient of the Healthcare Distribution Alliance’s (HDA) Distribution Management Award (DMA) for Industry Leadership.The award was presented today at the HDA Distribution Management Conference in Palm Desert, Calif.
Presented annually, the DMA for Industry Leadership honors pharmaceutical supply chain leaders who have made extraordinary contributions to the healthcare distribution industry. Winners exhibit the highest standards of honesty and integrity and have worked tirelessly — through their own company and through HDA — to enhance industry relations as well as supply chain efficiency and security. Morgan was selected by the distributor and manufacturer member executives of the HDA Industry Relations Council.
“Kay is well regarded by many in the pharmaceutical supply chain for her deep knowledge of the drug compendia and industry standards,” said John M. Gray, President and CEO, HDA. “From her willingness to educate trading partners who are launching products (or making changes to them), to her commitment to enhancing trade relations through her HDA participation, Kay truly embodies the qualities of the DMA for Industry Leadership.”
After receiving her BS in pharmacy at the University of Missouri, Morgan began her more than 40-year career at Abbott Laboratories. At Abbott she served nearly 25 years in various positions, including National Manager of Professional Relations and Third-Party Payers and Manager of Pharmaceutical Information/Patient Assistance. She then joined First DataBank as the Manager of the firm’s Product Knowledge Base Services, handling the U.S. pricing file (a component of the National Drug Data File).
Morgan joined Elsevier in 2005 as Vice President of Drug Products, overseeing the product data in Gold Standard’s drug databases. Now Vice President for Drug Products and Industry Standards for Elsevier Clinical Solutions, she oversees product and clinical content for the Gold Standard Drug Database, Clinical Pharmacology and ProspectoRx products, among others. She also reviews existing and new products for compliance with industry standards.
Morgan has been a member and active participant of HDA for more than 20 years, regularly attending Alliance conferences and serving as a mentor in the HDA Mentoring Program. She serves on the Board of Trustees for the National Council of Prescription Drug Programs (NCPDP), as well as several work groups, and makes a point of connecting with new members to help them make the most of their membership. Morgan also is a member of the National Association of Chain Drug Stores and American Society of Health-System Pharmacists.
She has been honored with numerous professional awards, including the Abbott Laboratories President’s (1987, 1990) and Chairman’s (1994) Awards, and in 2012, The Individual Membership Excellence (TIME) Award from NCPDP, the group’s highest honor. Additionally, she actively participates in the Dean’s Advisory Council at the University of Missouri.
Michael Conley, Vice President and Head, Trade Operations and Analytics, Novartis Pharmaceuticals, said, “An industry icon, Kay is always willing to share her expertise in product listing intricacies and ensure that a company’s product information is accurate and appropriate. She is not only a pleasure to work with, but appreciated by all who interact with her. The 2017 Distribution Management Award for Industry Leadership is a well-deserved recognition of Kay’s commitment to her work and the industry.”
Previous DMA for Industry Leadership honorees include Hal Harrison of Mutual Wholesale Drug Company, Stephen Seid, formerly with Purdue Pharma, L.P.; Elizabeth A. Gallenagh, Esq., HDA Senior Vice President of Government Affairs and General Counsel; and Neil Warren, formerly with Cardinal Health.
ABOUT THE HEALTHCARE DISTRIBUTION ALLIANCE
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.